Of those, cancer immune system related programmed cell death protein 1 (PD-1) and its ligand (PD-L1), endosomal/vacuolar and OX40 signalling pathways were among the highly significant pathway enrichments (Figure 2A, Table S2). Here, TNFRSF4 is linked to cancer.